翔宇医疗
(688626)
| 流通市值：43.94亿 | | | 总市值：43.94亿 |
| 流通股本：1.60亿 | | | 总股本：1.60亿 |
| 报告期 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 674,347,252.31 | 758,930,002.21 | 663,783,494.21 | 808,248,306.73 |
| 应收票据及应收账款 | 61,062,283.31 | 56,916,501.32 | 54,885,177.69 | 36,018,381.85 |
| 其中：应收票据 | 764,676.02 | 192,090.91 | 976,000 | 300,000 |
| 应收账款 | 60,297,607.29 | 56,724,410.41 | 53,909,177.69 | 35,718,381.85 |
| 应收款项融资 | 300,000 | 300,000 | 300,000 | - |
| 预付款项 | 44,418,453.5 | 33,888,651.68 | 32,290,965.58 | 28,619,433.93 |
| 其他应收款合计 | 11,589,741.31 | 9,294,251.63 | 7,417,506.52 | 9,034,105.41 |
| 存货 | 244,747,938.77 | 243,465,927.15 | 241,366,072.32 | 238,463,080.2 |
| 合同资产 | 2,785,690.22 | 4,931,662.27 | 2,804,401.44 | 529,171.35 |
| 其他流动资产 | 40,308,595.39 | 27,275,194.35 | 29,306,880.98 | 17,136,015.85 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,079,559,954.81 | 1,302,979,412.83 | 1,194,347,026.51 | 1,401,095,106.44 |
| 非流动资产: | | | | |
| 长期应收款 | 42,983,809.45 | 44,756,153.84 | 45,622,848.01 | 44,173,241.95 |
| 长期股权投资 | 13,156,431.61 | 12,935,334.49 | 13,113,239.99 | 17,050,910.97 |
| 其他权益工具投资 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| 固定资产 | 513,839,137.04 | 403,559,132.35 | 396,899,151.13 | 89,601,673.52 |
| 在建工程 | 495,901,899.15 | 471,196,354.07 | 428,830,970.69 | 574,421,766.49 |
| 使用权资产 | 5,807,915.73 | 8,028,105.23 | 8,630,421.65 | - |
| 无形资产 | 208,557,731.77 | 207,417,649.81 | 207,699,347.11 | 200,780,092.71 |
| 长期待摊费用 | 5,837,657.89 | 5,938,387.27 | 5,716,318.65 | 990,175.25 |
| 递延所得税资产 | 7,699,026.73 | 10,817,709.16 | 11,219,237.01 | 19,237,016.07 |
| 其他非流动资产 | 273,734,582.12 | 289,259,815.76 | 270,041,950.78 | 306,875,756.21 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,577,518,191.49 | 1,463,908,641.98 | 1,397,773,485.02 | 1,263,130,633.17 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,657,078,146.3 | 2,766,888,054.81 | 2,592,120,511.53 | 2,664,225,739.61 |
| 流动负债: | | | | |
| 短期借款 | 216,990,000 | 287,015,000 | 27,015,000 | 236,154,255 |
| 应付票据及应付账款 | 95,475,452.87 | 86,458,125.51 | 109,889,145.66 | 78,579,526.94 |
| 其中：应付票据 | 4,541,601.27 | 2,694,509.4 | 6,692,414.13 | 16,598,604.21 |
| 应付账款 | 90,933,851.6 | 83,763,616.11 | 103,196,731.53 | 61,980,922.73 |
| 合同负债 | 104,032,190.08 | 91,145,311.19 | 107,555,064.92 | 82,162,739.07 |
| 应付职工薪酬 | 24,354,637.08 | 22,587,175.8 | 23,344,477.5 | 20,092,601.11 |
| 应交税费 | 7,891,212.07 | 5,630,852.99 | 12,849,035.74 | 8,225,914.59 |
| 其他应付款合计 | 52,870,731.63 | 53,631,857.81 | 74,693,534.21 | 49,162,382.4 |
| 其他流动负债 | 14,567,016.32 | 13,345,418.82 | 16,794,132.73 | 11,986,944.35 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 516,181,240.05 | 559,813,742.12 | 372,140,390.76 | 486,364,363.46 |
| 非流动负债: | | | | |
| 租赁负债 | 6,325,787.55 | 8,543,099.79 | 8,443,005.74 | - |
| 递延收益 | 104,581,523.54 | 104,372,722.43 | 104,109,085.32 | 108,177,684.21 |
| 递延所得税负债 | - | - | - | 10,957,902.69 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 110,907,311.09 | 112,915,822.22 | 112,552,091.06 | 119,135,586.9 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 627,088,551.14 | 672,729,564.34 | 484,692,481.82 | 605,499,950.36 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 160,000,000 | 160,000,000 | 160,000,000 | 160,000,000 |
| 资本公积 | 1,299,395,219.95 | 1,297,002,183.81 | 1,294,137,332.62 | 1,294,158,697.03 |
| 减:库存股 | 155,624,061.27 | 153,791,981.95 | 98,931,608.86 | 96,689,309.08 |
| 盈余公积 | 80,000,000 | 80,000,000 | 80,000,000 | 58,946,461.82 |
| 未分配利润 | 629,736,410 | 694,769,020.11 | 655,695,191.59 | 628,768,535.66 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,013,507,568.68 | 2,077,979,221.97 | 2,090,900,915.35 | 2,045,184,385.43 |
| 少数股东权益 | 16,482,026.48 | 16,179,268.5 | 16,527,114.36 | 13,541,403.82 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,029,989,595.16 | 2,094,158,490.47 | 2,107,428,029.71 | 2,058,725,789.25 |
| 负债和股东权益合计 | 2,657,078,146.3 | 2,766,888,054.81 | 2,592,120,511.53 | 2,664,225,739.61 |
| 公告日期 | 2024-08-30 | 2024-04-18 | 2024-04-18 | 2023-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |